Our group consists of over 20 scientists working on COVID19 drug discovery, with a focus on computational aided drug design. We are an open science, non-profit group.
Dr. Ho Leung Ng, founder of the Open Source COVID19 (OSC19) Drug Discovery program, is Associate Professor of Biochemistry & Molecular Biophysics at Kansas State University. He is the author of 40 research publications in leading journals such as Science, PNAS, JACS, Nature Biotechnology, Nature Methods. His research relates to structure-based and computational drug design. He enjoys technology development, interdisciplinary collaboration, and mentoring. He believes strongly in the value of industry-academia collaboration.
Dr. Yousef Najajreh earned a Ph.D. from Hebrew University, Jerusalem. Since 2014, he has been the head of the Anticancer Drugs Research Lab, and he is also an Associate Professor in the Faculty of Pharmacy, Al-Quds University, Palestine. He has a diverse research background, such as in new drugs to treat cancer and obesity, and improve cognitive function. He is also active in improving access to high-quality education across Palestine, and developing a Ph.D. program in water quality in Palestine. Dr. Najajreh’s expertise in synthetic medicinal chemistry is invaluable for putting computational drug discovery findings into practice.
Dr. Venkatesh Natarajan earned a Ph.D. from the Indian Institute of Science, Bengaluru. Since 2015, he has been an Assistant Professor of Research Medicine at the University of Southern California, Los Angeles. He is a highly successful project manager for drug discovery, especially at managing collaborations between academic laboratories and biotechnology companies. Much of his recent work focuses on using the immune system to treat cancer; for example, designing antibodies to target cancer cells, and developing pertinent laboratory assays. Dr. Natarajan’s expertise in protein therapeutics and multi-institutional collaboration is especially useful for evaluating possible protein-based therapies for COVID-19.
Dr. Muhammad Mohsin Tariq earned a B.E. from the University of Engineering and Technology, Peshawar. Since January 2019, he has been a team leader at the National Center for Big Data and Cloud Computing, Peshawar. He is an accomplished data scientist with expertise across many technologies and domains. His recent work focuses on medical diagnostics, remote sensing, and computational drug discovery. Mr. Tariq’s expertise in nonprofits and startups, and competence across technologies, are particularly valuable assets.